Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription


[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

Re: question re comt inhibitors


In a message dated 10/23/99 2:59:48 AM Central Daylight Time,
janet313@xxxxxxxxxxx writes:

<<
 if the work that this class of med does
 [saving lovely levodopa from arterial ambush by those vile venous comt
conspirators]
 is done in the bloodstream prior to arrival at the brain station
 why would either of them have to cross the blood brain barrier?
 anyway?
  >>

Janet,
On behalf of those maligned Catachol O Methyl Transferases,I afta say tat
they are just doing their job, Ma'am.  Why have one act within the BBB?  In
the normal brain, Monoamine oxidase and COMT are responsible for cleaning up
left over dopamine.  However, in the PD brain there is no excess.

The idea behind inhibitors as PD therapy is preserving dopamine for use by
the brain not capable of producing adequate supplies of its own.  Dopamine in
the synapse is sorta where "the rubber meets the road. "  Avoiding breakdown
in the extra BBB area would be helpful too, but not as helpful.  I predict
that entacapone will be the "weaker " of the two drugs.


Best ,
WHH


Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance